Intermountain Ventures

Intermountain Ventures is the strategic venture capital and innovation arm of Intermountain Health, one of the largest not-for-profit healthcare systems in the western United States, headquartered in Salt Lake City, Utah. Founded in 2012, the firm invests in transformational early- and growth-stage companies aimed at improving healthcare delivery, operations, patient experience, and clinical outcomes. Managing Partner Nickolas Mark leads a team of nine, including three partners, deploying $1 to $5 million per company across Series A, B, and C rounds. Six primary investment focus areas structure the portfolio: Enterprise Enablement, Care Site Optimization, Workforce Transformation, Consumer Experience, Clinical Advancement, and Proactive Care. As of January 2026, Intermountain Ventures has invested in 27 companies with an exceptional exit record. The portfolio includes 2 unicorns in Freenome Health and Olive, and 3 IPOs: Omada Health on NASDAQ in June 2025 at a $1.06 billion market cap and Recursion Pharmaceuticals on NASDAQ at a $2.92 billion market cap. Ten acquisitions have been completed, including Armis, which was acquired by ServiceNow in December 2025 for $7.75 billion — a cybersecurity outlier that represents one of the largest outcomes from a healthcare-focused CVC portfolio. The most recent investment was knownwell at Series B in October 2025, with four total investments made in 2025. Intermountain Ventures provides portfolio companies with clinical expertise, de-identified data access, and integration opportunities within the Intermountain Health system, creating a meaningful channel for real-world validation that pure financial investors cannot match. The firm co-invests with other health system venture arms including Triventures, Health Enterprise Partners, and Ascension Ventures. Intermountain Health has also joined Microsoft, Gates Ventures, Epic, and West Health in an initiative to address healthcare access challenges in rural America.